Clinical Trials Logo

Flash Glucose Monitoring clinical trials

View clinical trials related to Flash Glucose Monitoring.

Filter by:
  • None
  • Page 1

NCT ID: NCT04797416 Active, not recruiting - Type 2 Diabetes Clinical Trials

The Evaluation of Consistency by Finger Stick Blood Glucose or Venous Blood Glucose of Flash Glucose Monitoring in Different Infiltration Time

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

This is a prospective randomized controlled study to evaluate consistency by finger stick blood glucose or venous blood glucose in different infiltration time (including the time between activation of the sensor and storage of the first blood glucose value) of Flash glucose monitoring(FGM). In this study, the relationship between the dynamic blood glucose and finger stick blood glucose or venous blood glucose in type 2 diabetes mellitus patients(T2DM), was explored. And the investigators also analyzed the deviation and accuracy of FGM in practical application,so as to provide a good reference for clinical application.

NCT ID: NCT04564911 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 2

GLucose Monitoring Programme SingaporE, Phase 2 (GLiMPSE2)

GLiMPSE2
Start date: December 22, 2020
Phase: N/A
Study type: Interventional

Many with type 2 diabetes (T2D) remain sub-optimally controlled. Structured programmes requiring dietary and lifestyle intervention have been shown to improve control but are time-and labour-intensive. The role for self-monitoring of blood glucose with capillary blood glucose (CBG) readings is uncertain. The use of flash glucose monitoring (FGM) with education may effect improvements in awareness and self-management behaviour and hence glycaemic control. The investigators aim to compare the effects of FGM versus CBG fingersticks in the context of a structured education programme over a 6-month period in adults with type 2 diabetes. 200 adults (>21y) with sub-optimally controlled T2D (7.5-10%) on either diet-controlled, oral glucose lowering drugs or background insulin will be enrolled and randomised into the intervention arm (FGM and education) or control arm (capillary glucose fingersticks and education). The intervention arm will monitor glucose using FGM continuously for 6 weeks and intermittently thereafter up to 24 weeks. The control group will monitor glucose using CBG fingersticks up to 24 weeks. During the intervention period(0-24w), both arms will undergo the same schedule of visits (-2w, 0w, 8w, 16w, 24w) and 6 education sessions. Both groups will be followed up at weeks 38 and 52. Primary outcome is HbA1c change from baseline at 24 weeks. This study will provide novel data on the use of FGM versus CBG in Type 2 diabetes and its impact on glycaemic control.

NCT ID: NCT04535830 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

The Effectiveness of Flash Glucose Monitoring System on Glycemic Control in Patients With New-onset Type 2 Diabetes

Start date: April 1, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if Flash glucose monitoring system improves glycemic control in adults with new-onset type 2 diabetes

NCT ID: NCT03071159 Recruiting - Metabolic Control Clinical Trials

An Evaluation of the FreeStyle Libre Flash Glucose Monitoring System

Start date: March 10, 2017
Phase: N/A
Study type: Interventional

Medium-term (6-12 months) evaluation of the use, the identified problems, the usability and the effect on the metabolic control of the FreeStyle Flash Libre glucose monitoring system in 90 children by questionnaires and routine measurement of HbA1c values.

NCT ID: NCT02824549 Recruiting - Clinical trials for Flash Glucose Monitoring

An Evaluation of the FreeStyle Flash Glucose Monitoring System

Start date: July 2016
Phase: N/A
Study type: Observational

The usability, skin reactions and accuracy of the FreeStyle Libre glucose monitoring system in children will be evaluated by questionnaires, pictures of the insertion site and comparison of the glucose results with capillary blood glucose determinations.